1. Home
  2. MGYR vs AGEN Comparison

MGYR vs AGEN Comparison

Compare MGYR & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$17.24

Market Cap

111.2M

Sector

Finance

ML Signal

N/A

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.79

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
AGEN
Founded
1922
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
126.8M
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
MGYR
AGEN
Price
$17.24
$3.79
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
3.5K
456.3K
Earning Date
01-22-2026
11-10-2025
Dividend Yield
2.09%
N/A
EPS Growth
27.11
N/A
EPS
1.56
N/A
Revenue
$35,207,000.00
$106,829,000.00
Revenue This Year
N/A
$67.15
Revenue Next Year
N/A
N/A
P/E Ratio
$11.05
N/A
Revenue Growth
11.78
N/A
52 Week Low
$13.52
$1.38
52 Week High
$19.04
$7.34

Technical Indicators

Market Signals
Indicator
MGYR
AGEN
Relative Strength Index (RSI) 61.43 38.61
Support Level $16.62 $3.82
Resistance Level $17.00 $4.12
Average True Range (ATR) 0.18 0.20
MACD 0.05 -0.04
Stochastic Oscillator 100.00 0.58

Price Performance

Historical Comparison
MGYR
AGEN

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Share on Social Networks: